- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/56 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
Patent holdings for IPC class A61K 47/56
Total number of patents in this class: 333
10-year publication summary
|
10
|
10
|
24
|
37
|
32
|
49
|
51
|
43
|
32
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hanmi Pharm. Co., Ltd. | 546 |
9 |
| Starpharma Pty Limited | 70 |
9 |
| Ascendis Pharma A/S | 173 |
8 |
| Massachusetts Institute of Technology | 9795 |
5 |
| The Johns Hopkins University | 5377 |
5 |
| Halozyme, Inc. | 120 |
5 |
| Ophidion Inc. | 8 |
5 |
| Selecta Biosciences, Inc. | 190 |
5 |
| Ashvattha Therapeutics, Inc. | 22 |
5 |
| The Regents of the University of California | 18943 |
4 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
4 |
| Nektar Therapeutics | 503 |
4 |
| University of Maryland, Baltimore | 999 |
4 |
| Dyne Therapeutics, Inc. | 157 |
4 |
| Code Biotherapeutics, Inc. | 17 |
4 |
| Barinthus Biotherapeutics North America, Inc. | 12 |
4 |
| AstraZeneca AB | 3042 |
3 |
| The Trustees of Columbia University in the City of New York | 3440 |
3 |
| ANP Technologies, Inc. | 51 |
3 |
| Ascendis Pharma GmbH | 7 |
3 |
| Other owners | 237 |